MONTREAL, /CNW/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for inherited cardiac arrhythmias, ...
Agreement positions NeuralCloud's AI-driven cardiac platform for Holter monitoring and ambulatory patient workflow. Partnership introduces CardioYield™ powered by MaxYield™ for automated, reliable ...
Researchers developed an AI model to detect myocardial ischemia and coronary microvascular and vasomotor dysfunction using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback